Demographic data for the SEEG patient cohorta
ID | EZ location | Age (yr) | Sex | Medication | Outcome (Engel score) |
---|---|---|---|---|---|
1 | Right mesial frontal | 21 | M | Carbamazepine 600 mg, Levetiracetam 1500 mg | IB (8 yr) |
2 | Right temporal insular | 26 | M | Carbamazepine 1200 mg, Primidone 750 mg, Clonazepam 10 mg | IA (37 mo) |
3 | Right temporal | 38 | M | Carbamazepine 1200 mg, Dilantin 450 mg, Lacosamide 300 mg, Clonazepam 10 mg | No surgery |
4 | Left temporo-parietal | 38 | F | Phenobarbital 100 mg, Topiramate 100 mg, Levetiracetam 3000 mg | IA (25 mo) |
5 | Left temporal-insular | 24 | M | Oxcarbazepine 600 mg, Lacosamide 400 mg | IA (15 mo) |
6 | Right temporo-insular | 40 | F | Levetiracetam 1000 mg, Lacosamide 350 mg, Sertraline 50 mg, Lorazepam 1 mg | IIIA (32 mo) |
7 | Precuneus | 19 | M | Oxcarbazepine 600 mg, Lacosamide 400 mg | No surgery |
8 | Functional epilepsy | 20 | F | Carbamazepine 1200 mg, Levetiracetam 1500 mg | No surgery |
9 | Right occipito-temporo-parietal | 20 | M | Lamotrigine 400 mg, Levetiracetam 3000 mg, Lacosamide 400 mg | IA (3 yr) |
10 | Left temporal | 35 | M | Topiramate 200 mg, Carbamazepine 900 mg | IA (12 mo) |
11 | Right temporal anterior | 28 | M | Carbamazepine 1200 mg | IIA (66 mo) |
12 | Temporo-hip | 36 | F | Carbamazepine 1400 mg, Levetiracetam 3000 mg | IIA (6 mo) |
13 | Left frontal anterior | 40 | M | Levetiracetam 2750 mg, Carbamazepine 800 mg, Primidone 750 mg | IA (12 mo) |
14 | Thermo-coagulation multiple sites | 39 | M | Oxcarbazepine 1800 mg, Clobazam 20 mg | IA (36 mo) |
15 | Right fronto-temporo-insular | 24 | F | Carbamazepine 1000 mg, Clobazam 20 mg, Lamotrigine 200 mg | IVA (24 mo) |
16 | Left parieto-opercolo-insular | 31 | F | Carbamazepine 1200 mg, Clobazam 40 mg, Phenobarbital 75 mg | IVA (12 mo) |
17 | Right temporo-perisylvian | 34 | F | Phenobarbital 150 mg, Lacosamide 400 mg, Clobazam 10 mg | IIC (38 mo) |
18 | Right perisylvian-insular | 17 | M | Carbamazepine 800 mg, Lamotrigine 400 mg | IVA (26 mo) |
19 | Right temporo-parieto-occipital | 36 | M | Oxcarbazepine 1200 mg, Phenobarbital 150 mg, Valproate 1000 mg | IA (35 mo) |
20 | — | 32 | F | Carbamazepine 700 mg | No surgery |
21 | Left temporal antero-mesial | 32 | M | Carbamazepine 1200 mg, Levetiracetam 750 mg | IA (61 mo) |
22 | Right fronto-centro-insular | 33 | M | Carbamazepine 800 mg, Lacosamide 800 mg, Zonisamide 250 mg | IIA (38 mo) |
23 | Left temporal | 21 | F | Levetiracetam 1750 mg, Lacosamide 400 mg, Valproate1000 mg | IA (24 mo) |
24 | Right parietal | 23 | M | Levetiracetam 3000 mg, CBZ 1000 mg, Lacosamide 500 mg | IA (24 mo) |
25 | Thermo-coagulation | 46 | M | Carbamazepine 1200 mg, Phenobarbital 100 mg | IA (24 mo) |
26 | Right frontal | 20 | F | Valproate 800 mg, Clobazam 10 mg | IIA (36 mo) |
27 | Right fronto-mesial | 21 | M | Carbamazepine 800 mg, Levetiracetam 3000 mg, Nitrazepam 1.5 mg | IIIA (13 mo) |
28 | Right fronto-central | 22 | M | Lamotrigine 400 mg, Levetiracetam 2000 mg | IA (24 mo) |
29 | Right frontal | 20 | M | Carbamazepine 600 mg, Rufinamide 1500 mg | IVA (13 mo) |
30 | Right frontal | 44 | F | Carbamazepine 1200 mg, Zonisamide 400 mg, Phenobarbital 1000 mg | IC (24 mo) |
31 | — | 17 | M | Carbamazepine 300 mg | No surgery |
32 | — | 14 | M | Levetiracetam 1500 mg, Clobazam 5 mg | No surgery |
33 | Right temporal antero-mesial | 30 | F | Oxcarbazepine 2000 mg, Phenobarbital 150 mg | IIA (36 mo) |
34 | — | 24 | M | Carbamazepine 16000 mg, Levetiracetam 4000 mg | No surgery |
35 | — | 29 | F | Levetiracetam 3000 mg | No surgery |
36 | Right orbito-temporal | 29 | F | Zonisamide 400 mg, Levetiracetam 750 mg, Carbamazepine 1400 mg | IA (62 mo) |
37 | — | 45 | F | Lacosamide 500 mg, Valproate 1000 mg, Zonisamide 200 mg | No surgery |
38 | Thermo-coagulation multiple sites | 34 | F | Carbamazepine 1000 mg, Levetiracetam 2500 mg | IA (12 mo) |
39 | Thermo-coagulation multiple sites | 50 | M | Levetiracetam 2000 mg, Lacosamide 600 mg | IIA (6 mo) |
40 | Left occipital | 17 | F | Carbamazepine 1200 mg, Levetiracetam 1500 mg, Lacosamide 300 mg | IB (49 mo) |
41 | Right temporal | 44 | F | Topiramate 300 mg, Oxcarbazepine 1200 mg | IIA (50 mo) |
42 | — | 27 | M | Carbamazepine 800 mg, Lamotrigine 200 mg | No surgery |
43 | — | 46 | M | Carbamazepine 1200 mg, Levetiracetam 3000 mg, Lacosamide 150 mg, Clobazam 20 mg | No surgery |
44 | Right antero-frontal | 28 | M | Carbamazepine 1000 mg, Levetiracetam 1000 mg | IIIA (61 mo) |
45 | Thermo-coagulation right temporo-parieto-perisylvian | 27 | F | Topiramate 200 mg, Lamotrigine 200 mg | IA (5 yr) |
46 | Right temporal antero-mesial | 42 | F | Lacosamide 500 mg | IB (36 mo) |
47 | Left parieto-temporal | 15 | M | Carbamazepine 900 mg | IA (6 mo) |
48 | Thermo-coagulation right temporo-opercular | 37 | M | Carbamazepine 900 mg, Levetiracetam 3000 mg | IVA (12 mo) |
49 | Left frontal | 30 | F | Carbamazepine 1200 mg, Lamotrigine 200 mg, Clobazam 20 mg | IA (5 yr) |
50 | Left frontal | 15 | F | Levetiracetam 1250 mg, Oxcarbazepine 1200 mg | IA (4 yr) |
51 | Thermo-coagulation | 41 | M | Levetiracetam 3000 mg, Lacosamide 400 mg | IA (2 yr) |
52 | Right temporo-occipital | 37 | M | Lamotrigine 600 mg, Levetiracetam 2000 mg | IA (2 yr) |
53 | Right temporal | 29 | M | Carbamazepine 1400 mg, Levetiracetam 3000 mg, Clobazam 10 mg | IA (31 mo) |
54 | Left opercolo-insular | 10 | F | Carbamazepine 800 mg | IIIA (34 mo) |
55 | Right temporo-frontal | 40 | F | Lamotrigine 600 mg, Clobazam 20 mg, Phenytoin 500 mg | IA (13 mo) |
56 | Left temporo-insular-operculum | 29 | F | Carbamazepine 1800 mg, Clobazam 20 mg | IA (24 mo) |
57 | Right temporal | 27 | M | Lamotrigine 400 mg, Topiramate 400 mg | IA (24 mo) |
58 | — | 26 | M | Phenytoin 400 mg, Topiramate 500 mg | No surgery |
59 | Left temporal | 17 | M | Oxcarbazepine 1500 mg, Clobazam 20 mg, Levetiracetam 2500 mg | IA (36 mo) |
60 | Right temporo-mesial | 25 | F | Topiramate 75 mg, Carbamazepine 1500 mg | IA (12 mo) |
61 | Nodular heterotopia | 24 | F | Carbamazepine 1000 mg, Levetiracetam 500 mg, Clobazam 20 mg | IVA (12 mo) |
62 | Left temporo-perisylvian | 37 | F | Carbamazepine 1200 mg, Lamotrigine 550 mg | IIIA (12 mo) |
63 | Left temporal antero-mesial | 32 | F | Clobazam 20 mg, Phenobarbital 45 mg | IIA (55 mo) |
64 | Right temporo-occipital | 44 | M | Carbamazepine 800 mg, Levetiracetam 3000 mg, Phenobarbital 125 mg | IA (24 mo) |
↵aEZ location indicates the supposed brain location of the EZ. Thermo-coagulation indicates the practice used in surgical intervention of drug-resistant focal epilepsy where current is injected in a bipolar derivation in order to increase the pericontact temperature. —, no single focal location was identified. Age indicates the age of the patients at the recording date. Drugs are reported with their active principal names. Drug dosage is expressed in milligrams and refers to the morning dosage measured at the day of the recording. Outcome is expressed as Engel scores. Numbers in parentheses indicate the point time after surgery when the visit occurred.